Clinical Trial Report

Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study

Shibata M, Nakamura T, Ozeki A, Ueda K, Nichols RM

Journal of Pain Research 2020, 13:3531-3538

Published Date: 31 December 2020